Treatment of Bipolar II Disorder
Introduction to Treatment
- The American Academy of Child and Adolescent Psychiatry recognizes lamotrigine as FDA-approved maintenance therapy particularly effective for preventing depressive episodes, which constitute approximately 75% of symptomatic time in bipolar II disorder 1
- Lithium provides unique anti-suicide effects independent of mood stabilization, reducing suicide attempts 8.6-fold and completed suicides 9-fold 1, 3
Evidence-Based Medication Selection
- Lamotrigine stands as the optimal long-term treatment for bipolar II depression, with demonstrated efficacy in multiple studies 1
- Quetiapine represents the only atypical antipsychotic with demonstrated efficacy in double-blind RCTs specifically for bipolar II disorder 1
- The American College of Physicians explicitly warns that SSRIs carry increased risk for suicide attempts compared with placebo 6
Special Considerations for Suicidal Ideation
- For patients with acute suicidal ideation, consider ketamine or esketamine as adjunctive treatment for short-term reduction in suicidal thoughts 4, 5
- Lithium carries significant overdose lethality requiring third-party medication supervision and limited quantities with frequent refills in patients with suicide history 1, 3
Treatment Phases and Duration
- Combination therapy with quetiapine plus lamotrigine provides superior acute control compared to monotherapy 1
- Continue the regimen that stabilized the acute episode for at least 12-24 months, as withdrawal dramatically increases relapse risk with >90% of noncompliant patients relapsing versus 37.5% of compliant patients 1, 2
Critical Medications to Avoid
- Antidepressant monotherapy is absolutely contraindicated in bipolar II disorder, as SSRIs can trigger manic/hypomanic episodes, cause mood destabilization, induce rapid cycling, and increase suicidal ideation 1, 2, 6
- If antidepressants are deemed necessary after 8 weeks of inadequate response to mood stabilizers, they must always be combined with lamotrigine or another mood stabilizer 1, 2
Monitoring Requirements
- Complete metabolic panel, liver function tests, renal function at baseline 1
- Pregnancy test in females of childbearing age at baseline 1
- Baseline weight, BMI, blood pressure, fasting glucose, lipid panel for quetiapine at baseline 1
Common Pitfalls to Avoid
- Rapid lamotrigine titration dramatically increases Stevens-Johnson syndrome risk, which can be fatal—never load lamotrigine rapidly 1
- Premature discontinuation of maintenance therapy leads to relapse rates exceeding 90%, particularly within the first 6 months following discontinuation 1, 2